Bon Natural Life’s main business focus on the research, development, production, and sales of active functional ingredients in the healthcare fields. Entering 2020, its business achieved a strong profitability with 84.8% net profit growth despite the impact of the pandemic. There are two major factors behind the bright performance of Bon Natural Life. One is the breakthrough and application of new technologies to improve product quality and thus win sales. Secondly, Bon Natural Life adjusted its product mix to reduce the proportion of low-margin, low-competitive products in the company’s business.
After a year and a half of preparation, it filed a prospectus with the SEC on December 7, 2020 to list on NASDAQ under the trading symbol “BNL”. Just one month later, TMI filed an updated F-1/A prospectus with the SEC on January 7, representing an acceleration of its listing process. (Source: finance.sina)